Melanoma patients are now being enrolled in the first clinical trial in the Midwest of an experimental vaccine that trains a patient’s immune system to fight the deadly cancer.
Melanoma patients are now being enrolled in the first clinical trial in the Midwest of an experimental vaccine that trains a patient’s immune system to fight the deadly cancer.